Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine is an urgent global health priority. This study evaluated the effectivenes...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Pierre Roques, Andrea Fritzer, Nathalie Dereuddre-Bosquet, Nina Wressnigg, Romana Hochreiter, Laetitia Bossevot, Quentin Pascal, Fabienne Guehenneux, Annegret Bitzer, Irena Corbic Ramljak, Roger Le Grand, Urban Lundberg, Andreas Meinke
Format: Artikel
Sprache:English
Veröffentlicht: American Society for Clinical investigation 2022-07-01
Schriftenreihe:JCI Insight
Schlagworte:
Infectious disease
Vaccines
Online Zugang:https://doi.org/10.1172/jci.insight.160173

Online

https://doi.org/10.1172/jci.insight.160173

Ähnliche Einträge